ID   MCF10AT1k.cl2
AC   CVCL_WM98
SY   MCF10AT1KCl.2; MCF10AT1K
DR   Wikidata; Q95986693
RX   PubMed=11261825;
RX   PubMed=14523048;
RX   PubMed=20543960;
CC   Transfected with: HGNC; 5173; HRAS (with p.Gly12Val).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Omics: Deep proteome analysis.
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_5554 ! MCF-10A-neoT
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 02-07-20; Version: 2
//
RX   PubMed=11261825; DOI=10.1023/A:1006461422273;
RA   Santner S.J., Dawson P.J., Tait L., Soule H.D., Eliason J.,
RA   Mohamed A.N., Wolman S.R., Heppner G.H., Miller F.R.;
RT   "Malignant MCF10CA1 cell lines derived from premalignant human breast
RT   epithelial MCF10AT cells.";
RL   Breast Cancer Res. Treat. 65:101-110(2001).
//
RX   PubMed=14523048; DOI=10.1172/JCI18899;
RA   Tang B., Vu M., Booker T., Santner S.J., Miller F.R., Anver M.R.,
RA   Wakefield L.M.;
RT   "TGF-beta switches from tumor suppressor to prometastatic factor in a
RT   model of breast cancer progression.";
RL   J. Clin. Invest. 112:1116-1124(2003).
//
RX   PubMed=20543960; DOI=10.1371/journal.pone.0011030;
RA   Choong L.-Y., Lim S., Chong P.-K., Wong C.-Y., Shah N., Lim Y.-P.;
RT   "Proteome-wide profiling of the MCF10AT breast cancer progression
RT   model.";
RL   PLoS ONE 5:E11030-E11030(2010).
//